Brainsway (BWAY) Income towards Parent Company (2018 - 2026)
Brainsway (BWAY) posted quarterly Income towards Parent Company of $2.3 million for Q1 2026, up 106.87% year-on-year from $1.1 million in Q1 2025, and down 31.13% on a QoQ basis from $3.3 million in Q4 2025.
Brainsway (BWAY) Income towards Parent Company (2018 - 2026) Analysis & Trends
Brainsway (BWAY) has reported Income towards Parent Company for 9 consecutive years, with $2.3 million the latest figure, recorded in Q1 2026.
- Quarterly Income towards Parent Company rose 106.87% year-over-year to $2.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.2 million (up 135.08% YoY) and the FY2025 annual result came in at $7.6 million, up 159.33% from the prior year.
- Income towards Parent Company slipped to $2.3 million in Q1 2026 per BWAY's latest filing, from $3.3 million in the prior quarter.
- Over the last five years, Income towards Parent Company for BWAY reached as high as $3.3 million in Q4 2025 and fell as low as -$5.0 million in Q3 2022.
- A 5-year average of -$253529.4 and a median of $127000.0 in 2023 frame the typical range for Income towards Parent Company.
- Annual changes were most pronounced in 2022 — Income towards Parent Company tumbled 187.08% — and 2024, when it jumped 1118.9%.
- Year by year, Income towards Parent Company stood at -$3.9 million in 2022, then surged by 103.28% to $127000.0 in 2023, then soared by 1118.9% to $1.5 million in 2024, then soared by 114.79% to $3.3 million in 2025, then slumped by 31.13% to $2.3 million in 2026.
- According to Business Quant data, Income towards Parent Company over the past three periods registered $2.3 million, $3.3 million, and $1.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Brainsway | 598.04 Mn | 538.27 Mn | 11.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.29 Mn |
| Dec 31, 2025 | 3.33 Mn |
| Sep 30, 2025 | 1.57 Mn |
| Jun 30, 2025 | 2.03 Mn |
| Mar 31, 2025 | 1.11 Mn |
| Dec 31, 2024 | 1.55 Mn |
| Sep 30, 2024 | 662,000.00 |
| Jun 30, 2024 | 600,000.00 |
| Mar 31, 2024 | 111,000.00 |
| Dec 31, 2023 | 127,000.00 |
| Sep 30, 2023 | -230,000.00 |
| Jun 30, 2023 | -1.66 Mn |
| Mar 31, 2023 | -2.43 Mn |
| Dec 31, 2022 | -3.87 Mn |
| Sep 30, 2022 | -5.04 Mn |
| Jun 30, 2022 | -2.45 Mn |
| Mar 31, 2022 | -1.99 Mn |
| Dec 31, 2021 | -1.35 Mn |
| Sep 30, 2021 | -1.80 Mn |
| Jun 30, 2021 | -1.94 Mn |